Comparison of Renal Amyloid and Hyaline Glomerulopathy in B6C3F1 Mice: An NTP Retrospective Study

Jessica S Hoane1, Crystal L Johnson1, James P Morrison1

  • 1Charles River Laboratories, Inc., Durham, North Carolina, USA.

Toxicologic Pathology
|March 23, 2016
PubMed

Insights

Hyaline glomerulopathy (HG) in B6C3F1 mice is often misdiagnosed as amyloidosis. This study confirms HG is distinct from amyloidosis using special stains and electron microscopy, improving diagnostic accuracy.

Area of Science:

  • Toxicologic Pathology
  • Nephropathology
  • Histopathology

Background:

  • Hyaline glomerulopathy (HG) can be mistaken for amyloidosis in toxicological studies.
  • Accurate discrimination between HG and amyloidosis is crucial for interpreting rodent study findings.

Purpose of the Study:

  • To determine if HG occurred in prior National Toxicology Program (NTP) studies.
  • To establish reliable methods for distinguishing HG from amyloidosis in B6C3F1 mice.

Main Methods:

  • Retrospective analysis of kidney slides from NTP archives.
  • Histochemical staining (H&E, PAS, CR, MT) and transmission electron microscopy.
  • Evaluation of control and suspected HG cases in B6C3F1 mice.

Main Results:

  • HG was reliably distinguished from amyloidosis using histochemical stains.
  • PAS-positive and CR-negative deposits were characteristic of HG.
  • Ultrastructural analysis confirmed HG in affected mice, differentiating it from amyloid.

Conclusions:

  • HG is a spontaneous, low-occurrence lesion in B6C3F1 mice, often misdiagnosed as amyloidosis.
  • PAS and CR staining improve the distinction between HG and amyloidosis.
  • Accurate diagnosis of HG is possible with appropriate histopathological techniques.

Related Concept Videos